Diaceutics PLC Cash Flow Reinvestment Rate
Diaceutics PLC cash flow reinvestment rate. Diaceutics PLC (DXRX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2025, reinvesting GBX16.00K (capex GBX16.00K ) from operating cash flow of GBX696.00K. Explore Diaceutics PLC (DXRX) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Diaceutics PLC (2016–2025)
Cash flow reinvestment rate of Diaceutics PLC from 2016 to 2025. Historical reinvestment intensity for Diaceutics PLC across 8 annual periods. Explore Diaceutics PLC (DXRX) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Diaceutics PLC Cash Flow Reinvestment Rate by Year (2016–2025)
Diaceutics PLC cash flow reinvestment rate by year from 2016 to 2025. Year-by-year capital reinvestment analysis for Diaceutics PLC. For the full cash flow conversion analysis, see Diaceutics PLC (DXRX) cash conversion ratio.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.05x | GBX71.00K | GBX1.50 Million | GBX71.00K | ▼ -99.6% |
| 2024 | 13.31x | GBX8.66 Million | GBX651.00K | GBX4.63 Million | ▲ +92.5% |
| 2023 | 6.91x | GBX9.06 Million | GBX1.31 Million | GBX4.86 Million | ▲ +265.9% |
| 2022 | 1.89x | GBX9.63 Million | GBX5.10 Million | GBX4.87 Million | ▼ -90.4% |
| 2021 | 19.65x | GBX11.20 Million | GBX570.00K | GBX5.60 Million | ▼ -60.5% |
| 2020 | 49.75x | GBX12.59 Million | GBX253.00K | GBX6.29 Million | ▲ +13390.3% |
| 2017 | 0.37x | GBX565.83K | GBX1.53 Million | GBX282.92K | ▲ +328.4% |
| 2016 | 0.09x | GBX58.03K | GBX674.01K | GBX29.03K | — |